Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
04/2000
04/12/2000EP0991946A1 Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor
04/12/2000EP0991945A2 Method for identification of tumor antigens with autoantibodies in serum
04/12/2000EP0991770A2 Prostate cancer gene
04/12/2000EP0991760A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof
04/12/2000EP0991759A1 Ntn-2 member of tnf ligand family
04/12/2000EP0991758A1 Smad6 and uses thereof
04/12/2000EP0991757A1 Novel tumor antigens
04/12/2000EP0991667A1 Antibodies to cryptosporidium
04/12/2000EP0991662A1 Chlamyidia trachomatis specific peptides and their use in diagnostic assays
04/12/2000EP0991423A1 Topical treatment of psoriasis using neutralizing antibodies to il-8
04/12/2000EP0991321A1 Tolerance to natural antibody antigens
04/12/2000EP0766825A4 Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions
04/12/2000EP0676052B1 Detection of cystic fibrosis or a cftr gene mutation
04/12/2000EP0642666B1 Hepatitis c assay
04/12/2000CN1250484A Diagnosis and treatment of glaucoma
04/12/2000CN1250479A Modulators of the function of receptors of the TNF/NGF receptor family
04/12/2000CN1250381A Remedies for lymphocytic tumors
04/12/2000CN1250098A Human P47 coding series and the polypeptide therewith and its preparation
04/12/2000CN1250097A New human gene coding series and the polypeptide therewith and its preparation
04/12/2000CN1250096A New human protein phosphatase subunit and its coding series and preparation
04/12/2000CN1250095A New human gene series and the polypeptide therewith and its preparation
04/12/2000CN1250094A New human kernon acceptor co-repressor coding series and the polypeptide therewith and its preparation
04/12/2000CN1250056A Pyloric bacillary spirillum resisting yolk immunoglobulin product and its application
04/11/2000US6048972 Polynucleotide sequences which code for reshaped human monoclonal antibody preferential to interleukins
04/11/2000US6048970 Prostate growth-associated membrane proteins
04/11/2000US6048967 Blood compound associated with a nitroxide compound to prevent or alleviate the side effects of oxygen stress
04/11/2000US6048966 Preventing blood loss using fibrinogenas a seal; incubation of fibrinogen with splitting enzyme with subseqent application of digested peptides to desired site of action
04/11/2000US6048963 Polynucleotides and polypeptides associated with benign prostatic hypertrophy
04/11/2000US6048962 Mammalian protein allergen; for the diagnosis and treatment of mammalian allergic response
04/11/2000US6048837 Dietetics
04/11/2000US6048729 Animal transfected clonal cells for the expression of therapeutic products
04/11/2000US6048717 Enzyme inhibitor that prevents cleavage by immunoglobulin; for treatment of asthma and autoimmune disease
04/11/2000US6048716 Microorganism polypeptide; for infection prevention bactericides; wound healing agents
04/11/2000US6048711 Human G-protein coupled receptor polynucleotides
04/11/2000US6048709 Polynucleotide sequence coding a endothelial marker polypeptide; for the detection and therapy of heart and vascular disorders
04/11/2000US6048705 Sandwich immunoassays for collagen type I degradation products
04/11/2000US6048704 Microfibrillar protein purified from human tissue which binds vein tissue antibody; for treatment and diagnosis of human vein tissue blockage disease
04/11/2000US6048703 Methods for detecting cell apoptosis
04/11/2000US6048702 Antibody which specifically binds to a oncogene modulating peptide; for the diagnosis and treatment of breast, prostate, or liver cancer; anticarcinogenic agents; antitumor agents
04/11/2000US6048536 Vaccine compositions
04/11/2000US6048528 Monoclonal antibody for diagnostic and therapeutic use in ovarian cancer
04/11/2000US6048527 Non-autoreactive; n-propionylated neisseria serogroup b capsular polysaccharide-protein conjugates
04/11/2000US6048526 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
04/11/2000CA2009946C Pasteurized, purified von willebrand factor concentrate and a process for the preparation thereof
04/06/2000WO2000019206A1 Ykl-40 as a marker and prognostic indicator for cancers
04/06/2000WO2000019205A1 Inhibition of pak activation of raf-1
04/06/2000WO2000018959A1 Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof
04/06/2000WO2000018923A2 Slgp protein and nucleic acid molecule and uses therefor
04/06/2000WO2000018919A1 Human kinesin-like motor protein
04/06/2000WO2000018918A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
04/06/2000WO2000018916A2 Human genes and gene expression products
04/06/2000WO2000018915A2 Membrane-associated organizational proteins
04/06/2000WO2000018912A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases
04/06/2000WO2000018910A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
04/06/2000WO2000018909A2 NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM)
04/06/2000WO2000018895A1 Short peptides which selectively modulate the activity of protein kinases
04/06/2000WO2000018888A1 Immunomodulation by genetic modification of dendritic cells and b-cells
04/06/2000WO2000018806A1 Bispecific and trispecific antibodies which specifically react with inducible surface antigens as operational target structures
04/06/2000WO2000018805A1 Novel antibodies, drugs containing these antibodies and methods for screening compounds by using these antibodies
04/06/2000WO2000018804A1 Tie2 agonist antibodies
04/06/2000WO2000018803A2 Antibodies to mammalian langerhans cell antigen and their uses
04/06/2000WO2000018801A2 Ncam binding compounds
04/06/2000WO2000018799A1 Artemin, a novel neurotrophic factor
04/06/2000WO2000018797A1 Map
04/06/2000WO2000018796A2 Secretory protein- zsig48
04/06/2000WO2000018795A2 Compositions and methods for wt1 specific immunotherapy
04/06/2000WO2000018782A2 Hrpca 9 and hrpca 10 nucleic acids and polypeptides
04/06/2000WO2000018438A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof
04/06/2000WO2000018437A1 Tie2 antagonist antibodies
04/06/2000WO2000018436A1 Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke
04/06/2000WO2000018435A1 Time-staggered utilization of tumor cells in combination with intact antibodies for immunization
04/06/2000WO2000018428A2 Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses therefor
04/06/2000WO2000018414A1 Transplantation of neural cells for the treatment of ischemic damage due to stroke
04/06/2000WO2000018409A1 Use of certain drugs for treating nerve root injury
04/06/2000WO2000018351A2 Aglyco products and methods of use
04/06/2000WO2000018336A1 Targeted therapy to a biomedical device
04/06/2000WO2000018212A2 Platelet-derived growth factor c, dna coding therefor, and uses thereof
04/06/2000WO1999067384A3 Prostate cancer-associated genes
04/06/2000WO1999064596A3 Proteins regulating gene expression
04/06/2000WO1999064584A3 Protein for regulating apoptosis
04/06/2000WO1999062941A3 Serpentine transmembrane antigens expressed in human cancers and uses thereof
04/06/2000WO1999061626A3 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase
04/06/2000WO1999061618A3 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
04/06/2000WO1999061468A3 The induction of antibiotic peptides by lait (scd14) protein
04/06/2000WO1999061453A3 priA
04/06/2000WO1999061057A3 Molecules targeting cd40 and tumor cells
04/06/2000WO1999059608A3 Osteoporosis treatment
04/06/2000WO1999058683A3 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)
04/06/2000WO1999057144A3 Human transcriptional regulator molecules
04/06/2000WO1999053051A3 5' ests and encoded human proteins
04/06/2000WO1999053042A3 Biological material with increased expression of endogenous complement regulatory molecules
04/06/2000WO1999038972A8 Human genes and gene expression products ii
04/06/2000WO1998050549A3 Two human g-protein coupled receptors: ebv-induced gpcr 2 (ebi-2) and edg-1-like gpcr
04/06/2000WO1996013594A8 Tumor-specific antibody fragments, fusion proteins, and uses thereof
04/06/2000CA2714449A1 Use of certain drugs for treating nerve root injury
04/06/2000CA2344766A1 Antibodies to mammalian langerhans cell antigen and their uses
04/06/2000CA2344742A1 Nucleic acids and proteins from cenarchaeum symbiosum
04/06/2000CA2344714A1 Hrpca 9 and hrpca 10 nucleic acids and polypeptides
04/06/2000CA2344712A1 Secretory protein- zsig48
04/06/2000CA2344658A1 Human kinesin-like motor protein